Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9051
CALL
Dorian LPG
LPG
$2.08B
| $397K | ﹤0.01% |
26,100
+15,600
| +149% | +$247K |
|
9052
CALL
Ring Energy
REI
$365M
| $397K | ﹤0.01% |
149,400
+35,000
| +31% | +$145K |
|
|
SFYX
9053
DELISTED
SoFi Next 500 ETF
SFYX
| $397K | ﹤0.01% |
37,064
+7,391
| +25% | +$88.9K |
|
9054
PUT
Titan Machinery
TITN
$425M
| $397K | ﹤0.01% |
17,700
-7,600
| -30% | -$189K |
|
9055
CALL
ProShares Ultra Financials
UYG
$844M
| $397K | ﹤0.01% |
9,200
+1,700
| +23% | +$88.5K |
|
9056
CALL
NewtekOne
NEWT
$371M
| $396K | ﹤0.01% |
20,900
-13,200
| -39% | -$317K |
|
9057
Vitamin Cottage Natural Grocers
NGVC
$631M
| $396K | ﹤0.01% |
24,872
-22,006
| -47% | -$409K |
|
9058
CALL
Global X SuperDividend US ETF
DIV
$783M
| $395K | ﹤0.01% |
20,300
+1,800
| +10% | +$36.9K |
|
9059
PUT
Hyliion Holdings
HYLN
$716M
| $395K | ﹤0.01% |
122,800
-20,200
| -14% | -$70.8K |
|
9060
CALL
InvenTrust Properties
IVT
$2.6B
| $395K | ﹤0.01% |
15,300
-1,300
| -8% | -$38K |
|
9061
CALL
The Joint Corp
JYNT
$119M
| $395K | ﹤0.01% |
25,800
-12,900
| -33% | -$288K |
|
9062
Pearson
PSO
$9.71B
| $395K | ﹤0.01% |
42,827
-221,468
| -84% | -$2.14M |
|
9063
CALL
Stepan Co
SCL
$1.47B
| $395K | ﹤0.01% |
3,900
-4,400
| -53% | -$455K |
|
|
QED
9064
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
| $395K | ﹤0.01% |
19,122
-26,140
| -58% | -$557K |
|
9065
Fidelity Total Bond ETF
FBND
$27.3B
| $394K | ﹤0.01% |
+8,457
| New | +$403K |
|
|
FRGE
9066
DELISTED
Forge Global Holdings
FRGE
| $394K | ﹤0.01% |
2,522
+2,091
| +485% | +$561K |
|
9067
CALL
Grid Dynamics Holdings
GDYN
$616M
| $394K | ﹤0.01% |
23,400
-400
| -2% | -$6.54K |
|
|
GOOD
9068
PUT
Gladstone Commercial Corp
GOOD
$622M
| $394K | ﹤0.01% |
20,900
+11,400
| +120% | +$232K |
|
9069
Vor Biopharma
VOR
$1.36B
| $394K | ﹤0.01% |
3,969
+1,089
| +38% | +$111K |
|
|
QQQH
9070
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $394K | ﹤0.01% |
10,250
-3,800
| -27% | -$168K |
|
|
AVDL
9071
DELISTED
Avadel Pharmaceuticals
AVDL
| $393K | ﹤0.01% |
161,062
+74,365
| +86% | +$305K |
|
9072
PUT
Banco Macro
BMA
$5.04B
| $393K | ﹤0.01% |
35,100
-18,100
| -34% | -$269K |
|
9073
CALL
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $393K | ﹤0.01% |
+4,700
| New | +$431K |
|
9074
Nuvectis Pharma
NVCT
$621M
| $393K | ﹤0.01% |
+35,069
| New | +$434K |
|
9075
PUT
Palomar
PLMR
$3.27B
| $393K | ﹤0.01% |
6,100
+200
| +3% | +$12.1K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.